A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With ARPKD Active United States Tagged as: ARPKD
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With ARPKD Active Tagged as: ARPKD
Genetics of Brain Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease Active Participate from home Tagged as: ADPKD
A Safety and Efficacy Study in Previously Transplanted Living Donor Kidney Recipients Following FCR001 Cell Therapy (FREEDOM-2) Inactive Illinois, United States
Polycystic Kidney Disease Repository Active Kansas City, Wyandotte County, Kansas, United States Tagged as: ADPKD
